Shanghai Sanyou Medical Co., Ltd (SHA: 688085), a leading medical device company based in China, has announced that it has received a Category III medical device license from the National Medical Products Administration (NMPA) for its cervical thoracic internal fixation system. This innovative product suite, which includes advanced implants and modular surgical instruments, is designed for posterior internal fixation of the occipital neck, cervical spine, and upper thoracic spine regions. The system’s design allows for minimally invasive procedures, ensuring precise treatment and ease of operation. It is indicated for the treatment of various conditions affecting the occipital, cervical, and upper thoracic vertebrae, including rheumatoid arthritis, congenital malformations, trauma, tumors, infections, and degenerative pain.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
